Ampicillin and Sulbactam for Injection

FEBRUARY 01, 2006

American Pharmaceutical Partners (Schaumburg, Ill) recently received FDA approval for its abbreviated new drug application for Ampicillin and Sulbactam for Injection. The product is the generic equivalent of Pfizer Inc's Unasyn. Ampicillin and Sulbactam is an injectable antibacterial combination consisting of the semisynthetic antibiotic ampicillin sodium and the beta-lactamase inhibitor sulbactam sodium. The product is indicated for the treatment of several skin and skin structure, intra-abdominal, and gynecologic infections due to susceptible strains of microorganisms. Administered intravenously or intramuscularly, Ampicillin and Sulbactam for Injection is available in 1.5-and 3-g single-dose vials. The product is preservative-free, and each vial will include a bar code and latex-free vial stopper. For more information, visit www.appdrugs.com.




SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.